Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy.
Date
2023-09-01ICR Author
Author
Wadsley, J
Ainsworth, G
Coulson, AB
Garcez, K
Moss, L
Newbold, K
Farnell, K
Swain, J
Howard, H
Beasley, M
Weaver, A
Wood, K
Marshall, J
Griffin, M
Pascoe, A
Du, Y
Taprogge, J
Flux, G
Brown, S
Type
Journal Article
Metadata
Show full item recordCollections
Subject
Humans
Iodine Radioisotopes
Iodine
Thyroid Neoplasms
Adenocarcinoma
Antineoplastic Agents
Research team
Radioisotope Physics
Language
eng
Date accepted
2023-09-01
License start date
2023-09-01
Citation
Thyroid, 2023, 33 (9), pp. 1119 - 1123
Publisher
MARY ANN LIEBERT, INC